GoodRx Holdings Inc
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
GDRX$3.65+4.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| (in thousands, except per share amounts) | 2024 | 2023 | 2024 | 2023 |
| Revenue | $195,251 | $179,958 | $593,741 | $553,621 |
| Costs and operating expenses: | ||||
| Cost of revenue, exclusive of depreciation and amortization presented separately below | 11,684 | 18,721 | 36,022 | 51,755 |
| Product development and technology | 30,139 | 39,611 | 92,010 | 103,804 |
| Sales and marketing | 89,867 | 91,615 | 273,285 | 247,577 |
| General and administrative | 25,619 | 35,317 | 94,316 | 95,144 |
| Depreciation and amortization | 17,535 | 33,024 | 50,442 | 64,060 |
| Total costs and operating expenses | 174,844 | 218,288 | 546,075 | 562,340 |
| Operating income (loss) | 20,407 | (38,330) | 47,666 | (8,719) |
| Other expense, net: | ||||
| Other expense | (2,660) | (2,200) | (2,660) | (4,008) |
| Loss on extinguishment of debt | (2,077) | — | (2,077) | — |
| Interest income | 4,797 | 8,649 | 18,686 | 23,697 |
| Interest expense | (12,355) | (14,720) | (41,564) | (41,907) |
| Total other expense, net | (12,295) | (8,271) | (27,615) | (22,218) |
| Income (loss) before income taxes | 8,112 | (46,601) | 20,051 | (30,937) |
| Income tax (expense) benefit | (4,147) | 8,106 | (10,401) | 47,938 |
| Net income (loss) | $3,965 | $(38,495) | $9,650 | $17,001 |
| Earnings (loss) per share: | ||||
| Basic | $0.01 | $(0.09) | $0.03 | $0.04 |
| Diluted | $0.01 | $(0.09) | $0.02 | $0.04 |
| Weighted average shares used in computing earnings (loss) per share: | ||||
| Basic | 379,667 | 413,437 | 385,553 | 412,698 |
| Diluted | 388,504 | 413,437 | 393,477 | 416,450 |
| Stock-based compensation included in costs and operating expenses: | ||||
| Cost of revenue | $86 | $146 | $226 | $487 |
| Product development and technology | 6,384 | 6,829 | 18,491 | 22,952 |
| Sales and marketing | 9,725 | 10,273 | 27,248 | 11,665 |
| General and administrative | 10,186 | 15,398 | 32,102 | 40,938 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.